乳腺癌新辅助化疗后影像学完全缓解的定义:术前超声与乳腺X线定位所见与病理学完全缓解的相关性
6年回顾性研究纳入93例接受新辅助化疗并行术前影像定位的乳腺癌病例,其中45例行超声定位、48例因超声无法界定残留肿块而行乳腺X线定位。超声定位对43个病理肿块正确预测42个(准确率98%),乳腺X线定位对43例病理学完全缓解正确预测40例(准确率93%)。作者将影像学完全缓解定义为超声与乳腺X线均无肿块、仅见活检后标记物覆盖于外观正常的乳腺实质,并建议为该征象分配BI-RADS分类。
要点
- 影像学完全缓解定义为超声和乳腺X线均无肿块、仅见活检后标记物覆盖于正常外观乳腺实质(标记物征)。
- 影像学完全缓解与病理学完全缓解的相关性为93%。
- 假阴性病例与致密乳腺覆盖及可能的治疗后反应有关。
核心结论
- 研究将影像学完全缓解定义为超声和乳腺X线评估中均无肿块、活检后组织标记物覆盖于外观正常的乳腺实质,该定义与病理学完全缓解的相关性为93%。
- 少数假阴性病例与致密乳腺覆盖及可能的治疗后反应有关。
- 作者建议为影像学完全缓解分配BI-RADS分类。
研究设计与样本
- 6年回顾性研究,纳入93例接受新辅助化疗且行术前影像定位的乳腺癌病例。
- 45例行超声定位,48例因超声未能界定任何残留肿块而行乳腺X线定位。
- 以病理报告记录的病理学完全缓解与否及背景改变为参考标准。
关键影像表现/征象
- 影像学完全缓解表现为无肿块、仅见活检后标记物覆盖于正常乳腺实质模式(超声与乳腺X线均可见标记物征)。
- 肿块或异常乳腺实质模式被视为残留肿瘤。
诊断标准与关键数值
- 超声定位对43个病理肿块正确预测42个,准确率98%。
- 乳腺X线定位对43例病理学完全缓解正确预测40例,准确率93%。
- 最佳应答者为三阴性及HER2阳性激素受体阴性乳腺癌。
临床应用与阅片要点
- 作者建议为影像学完全缓解分配BI-RADS分类。
局限性
- 原文为回顾性研究。
- 少数假阴性病例与致密乳腺覆盖及可能的治疗后反应有关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Breast cancer affects a significant number of patients younger than 40 years in the Gulf and breast conservative treatment is highly preferred. Pathological complete response (pCR) following neoadjuvant chemotherapy is increasingly being observed with the new chemotherapy agents. Although MRI is more accurate in such evaluations, digital mammography and high-resolution ultrasound (US) which are less expensive may accurately predict pCR which is the focus of this study.
METHODS: A 6-year retrospective study of 93 breast cancer cases who had neoadjuvant chemotherapy and had presurgical radiological localization was carried out. Forty-five had US localization while 48 underwent mammographic localization when US failed to define any residual mass. Radiologic complete response (rCR) was defined as absence of mass with only postbiopsy clip overlying normal breast parenchyma pattern in US and in mammography (clip sign). Mass or abnormal parenchymal pattern was considered as residual tumor. The pathology reports of pCR or not with background changes were recorded.
RESULTS: Ultrasound localization correctly predicted 42 out of 43 pathologic masses with 98 % accuracy. Mammographic localization correctly predicted 40 out of 43 pCR with 93 % accuracy. The best responders were triple negative and HER2 positive hormone negative breast cancer.
CONCLUSION: The study defines radiologic complete response (rCR) as absence of a mass with the postbiopsy tissue marker overlying a normal-looking breast parenchyma in both ultrasound and mammographic evaluation. A correlation of 93 % was found with pCR. The few false negative cases were associated with overlying dense breast and possibly post treatment reaction. Allocation of a BI-RADS category for rCR is suggested.
引用
- Makanjuola DI, Alkushi A, Al Anazi K, et al. Defining radiologic complete response using a correlation of presurgical ultrasound and mammographic localization findings with pathological complete response following neoadjuvant chemotherapy in breast cancer. Eur J Radiol. 2020. PMID: 32673929. doi:10.1016/j.ejrad.2020.109146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。